Nutritional High (CSE:EAT, OTCQB:SPLIF, FWB:2NU) is pleased to announce that Jim Frazier, CEO of Nutritional High, is scheduled to be a featured speaker at the Community-Led Cannabis Research Symposium hosted by the Cannabis Community Care and Research Network (C3RN).
Scheduled on September 23, 2018, the symposium is being hosted by C3RN in Boston, Massachusetts. Frazier will be presenting about “FLÏ™ Products: Innovation in the Cannabis Industry,” a topic which allows for an opportunity for Nutritional High to illustrate its focus on product innovation, social responsibility and cannabis education.
The Cannabis Community Care and Research Network is a company that specializes in providing high-quality advocacy, research, and education services related to Cannabis. As a social justice-oriented organization, C3RN specializes in designing, monitoring, and evaluating models of integrating adult-use and medical Cannabis to positively impact social, clinical, and public health outcomes. To learn more about the event, visit C3RN’s event page here:
Jim Frazier, the CEO of Nutritional High, commented, “On behalf of Nutritional High, I’m thrilled to be given the opportunity to speak at this C3RN event situated in the cannabis advocacy and awareness community. With the recent launch of programs such as FLÏ™ Safe and our newest FLÏ™ Chocolate Shot and FLÏ™ Space Joint product releases, now is the time to talk about the work that we’re doing in the cannabis industry to differentiate both our products and our social awareness initiatives.”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™ edibles and extracts product line from production to market through its wholly owned subsidiaries in California and Oregon, as well as Colorado where its FLÏ™ products are manufactured by a licensed producer. The Company distributes its products and products manufactured by other leading producers through its wholly owned distributor Calyx Brands Inc. The Company also owns a 50% interest in The Clinic Effingham (an Illinois dispensary), and is entering the Nevada, Washington State and Canadian markets in the near future.
For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit www.nutritionalhigh.com.
For further information or questions, contact:
Chairman of the Board
Nutritional High International Inc.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable real estate and raising sufficient financing to complete the Company’s business strategy. There is no certainty that any of these events will occur. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forwardlooking information or to publicly announce the result of any revisions to any of the forwardlooking information contained herein to reflect future results, events or developments, except as required by law.